A Study of Selpercatinib (LY3527723) in Healthy Participants

NCT05338515 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Selpercatinib

Sponsor

Eli Lilly and Company

Collaborators

[object Object]